Collaborate Across ADC Innovations to Differentiate, De-Risk, Validate & Raise Capital

Sep 9-10, Boston MA

Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADC conference calendar

CONFIRMED TO ATTEND

Why Attend?

Back for its second year, the ADC Partnering & Investment Summit unites 100+ top ADC companies, pharma leaders, and investors for hyper-aligned and more efficient business networking.
Unite with other ADC business development leaders where cutting-edge science meets strategic networking:

  • Connect directly with decision-makers in a less competitive setting
  • Understand how others are positioning themselves to refine your own differentiation
  • Gain insights from scientific pioneers shaping the future of ADCs to define your strategic direction

Since the conference 6 months ago we are already working with one contact and we're about to sign another. We're already making compounds they want to tes. The whole format was extremely useful. It's rare to just jump into a conference and come out with traction.

Biotech Chief Executive Officer, ADC Partnering & Investment Summit, 2024

ADC 218
ADC 143

SPEAKERS

Steve Bartz - ADC Partnering & Investment Summit 2025

Head of Oncology Search & Evaluation

Pfizer

Hong Xin - ADC Partnering & Investment Summit 2025

Senior Director, Search & Evaluation

Johnson & Johnson

Carla Bauer - ADC Partnering & Investment Summit 2025

Director, Oncology Search & Evaluation, Business Development

Merck

Adrianne Wong - ADC Partnering & Investment Summit 2025

Director, Oncology Search & Evaluation, Global Business Development

Daiichi Sankyo

Jenny Wang - ADC Partnering & Investment Summit 2025

Director II, Search & Evaluation Oncology

Abbvie

John Mayfield - ADC Partnering & Investment Summit 2025

Senior Vice President, Business Development & Strategy

Flagship Pioneering

Filippo Mulinacci - ADC Partnering & Investment Summit 2025

Chief Business Officer

Araris Biotech

Tim Wang - ADC Partnering & Investment Summit 2025

Chief Business Officer

Duality Biologics

Cookie Yu- ADC Partnering & Investment Summit 2025

Director, Investment

Samsung Venture Investment

Brian Zhou - ADC Partnering & Investment Summit 2025

Associate Director

Lily Venture

Networking format

Alignment with the Total Audience

Scientifically Relevant, Qualified Business Decision Makers

Unlike research conferences with scientific insights but a research-focused audience, or large partnering meetings with business leaders but diversity in interests, the ADC Partnering & Investment Summit intersects market-specific insights with a targeted critical mass of relevant decision-makers, so you have less competition and more time from those you are speaking to, all free from conflicting priorities and interested to talk to you.

One-on-One Partnering Portal

Schedule Meetings in Advance, with the Industry’s Best Partnering Portal

Prepare and pre-arrange your most important meetings by reviewing the full attendee list, company profiles and reaching out to fill your meeting calendar in advance. Guarantee 30-minute, 1-2-1 and face-to-face time, with pharma present in 70% of meetings and a 30% acceptance rate versus industry standard*.

*Statistics an average from 2024 and 2025 Partnering & Investment Summits by Hanson Wade

Protected Icebreaker Opportunity

Select Your Pharma, Sit at Their Table

As a contingency for pharma not having availability to accept all meetings, the pharma icebreaker roundtables on the morning of day one protects networking time, so you can have guaranteed introductions to your top pharma interests. One week out, tell us which pharma are missing in your schedule, and we’ll ensure you’re sat at those tables during the rotations across 90 minutes of pharma-to-biotech networking.

Meet Investors, Share your Business Card

To maximize the number of investors you can connect with, the icebreaker speed networking following the venture and investment panel, ensures you can swap business cards with all investors present. Join a high table and stay through short rounds of face-to-face investor introductions to ensure those relevant to your company stage, know who you are and can take your business card.

OTHER HANSON WADE SUMMITS